Unresectable stage III NSCLC: Platinum-doublet chemotherapy beneficial as second-line therapy Pediatric News , 25 Apr 2022 Key clinical point : Platinum-doublet chemotherapy as the second-line treatment may offer an overall survival (OS) advantage…